- Home
- SOAR vs SYRS Comparison
SOAR vs SYRS Comparison
Compare SOAR & SYRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOAR
- SYRS
- Stock Information
- Founded
- SOAR 2021
- SYRS 2011
- Country
- SOAR United States
- SYRS United States
- Employees
- SOAR N/A
- SYRS N/A
- Industry
- SOAR Blank Checks
- SYRS Biotechnology: Pharmaceutical Preparations
- Sector
- SOAR Finance
- SYRS Health Care
- Exchange
- SOAR Nasdaq
- SYRS Nasdaq
- Market Cap
- SOAR 5.5M
- SYRS 5.7M
- IPO Year
- SOAR N/A
- SYRS 2016
- Fundamental
- Price
- SOAR $0.15
- SYRS $0.17
- Analyst Decision
- SOAR
- SYRS Hold
- Analyst Count
- SOAR 0
- SYRS 5
- Target Price
- SOAR N/A
- SYRS $3.00
- AVG Volume (30 Days)
- SOAR 7.4M
- SYRS 1.2M
- Earning Date
- SOAR 03-25-2025
- SYRS 03-26-2025
- Dividend Yield
- SOAR N/A
- SYRS N/A
- EPS Growth
- SOAR N/A
- SYRS N/A
- EPS
- SOAR N/A
- SYRS N/A
- Revenue
- SOAR $102,271,000.00
- SYRS $386,000.00
- Revenue This Year
- SOAR N/A
- SYRS N/A
- Revenue Next Year
- SOAR N/A
- SYRS N/A
- P/E Ratio
- SOAR N/A
- SYRS N/A
- Revenue Growth
- SOAR 97.25
- SYRS N/A
- 52 Week Low
- SOAR $0.08
- SYRS $0.16
- 52 Week High
- SOAR $4.50
- SYRS $7.96
- Technical
- Relative Strength Index (RSI)
- SOAR 42.13
- SYRS 38.78
- Support Level
- SOAR $0.08
- SYRS $0.16
- Resistance Level
- SOAR $0.26
- SYRS $0.20
- Average True Range (ATR)
- SOAR 0.04
- SYRS 0.02
- MACD
- SOAR -0.00
- SYRS 0.01
- Stochastic Oscillator
- SOAR 38.07
- SYRS 35.75
About SOAR Volato Group Inc.
Volato Group Inc operates an aircraft ownership program, provides ad-hoc charter flights, sells deposit products, and manages aircraft for owners in the private aviation industry. It offers fractional ownership, aircraft management, jet cards, deposit, and charter programs. The company's fractional programs provides flexible hours and a revenue share for owners in a fleet of HondaJets, optimized for missions of up to four passengers.
About SYRS Syros Pharmaceuticals Inc.
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.